KAND567 Versus Placebo in Subjects Hospitalized With COVID-19

NCT06012565 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

Covid19

Interventions

DRUG: KAND567
DRUG: Microcrystalline cellulose

Sponsor

Novakand Pharma AB